1. McKay, James D, Hung, Rayjean J, Han, Younghun, Landi, Maria Teresa, Amos, Christopher I. 2017. Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes. In Nature genetics, 49, 1126-1132. doi:10.1038/ng.3892. https://pubmed.ncbi.nlm.nih.gov/28604730/
2. Lotfipour, Shahrdad, Byun, Janet S, Leach, Prescott, Gould, Thomas J, Boulter, Jim. . Targeted deletion of the mouse α2 nicotinic acetylcholine receptor subunit gene (Chrna2) potentiates nicotine-modulated behaviors. In The Journal of neuroscience : the official journal of the Society for Neuroscience, 33, 7728-41. doi:10.1523/JNEUROSCI.4731-12.2013. https://pubmed.ncbi.nlm.nih.gov/23637165/
3. Chen, Zhihong, Wang, Lingan, Wang, Chun, Guo, Yuxiong, Zhang, Yuxin. 2015. Mutational analysis of CHRNB2, CHRNA2 and CHRNA4 genes in Chinese population with autosomal dominant nocturnal frontal lobe epilepsy. In International journal of clinical and experimental medicine, 8, 9063-70. doi:. https://pubmed.ncbi.nlm.nih.gov/26309560/
4. Kim, Jinju. . Association of CHRNA2 polymorphisms with overweight/obesity and clinical characteristics in a Korean population. In Clinical chemistry and laboratory medicine, 46, 1085-9. doi:10.1515/CCLM.2008.230. https://pubmed.ncbi.nlm.nih.gov/18588430/
5. Trivisano, Marina, Terracciano, Alessandra, Milano, Teresa, Vigevano, Federico, Specchio, Nicola. 2015. Mutation of CHRNA2 in a family with benign familial infantile seizures: Potential role of nicotinic acetylcholine receptor in various phenotypes of epilepsy. In Epilepsia, 56, e53-7. doi:10.1111/epi.12967. https://pubmed.ncbi.nlm.nih.gov/25847220/